• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of atherosclerosis and thrombosis

    Journal of atherosclerosis and thrombosis

    JournalISSN 1340-3478eISSN 1880-3873中科院 医学 3区

    年发文量

    研究主题

    论文(3188)

    排序
    1Plasma Pyrophosphate Levels in Calcification of Joints and Arteries Compared with Generalized Arterial Calcification of Infancy
    Naoko Hidaka,Toshinari Takamura,Norihiko Sakai,Yo Niida, Hiroki Ura,Masato Tanaka,Hitoshi Nakazato,Soichiro Kimura,Hajime Kato, Natsuho Adachi, Koichiro Furukawa,Koki Irie,
    2026
    引用
    AI阅读
    加入学术空间
    2Phenotypic Characterization and Spatial Distribution of Eruptive Versus Non-Eruptive Calcified Nodules: A Comparative Multimodality Imaging Analysis
    Takumi Watanabe,Eisuke Usui,Yoshihisa Kanaji,Hiroki Ueno,Kodai Sayama, Takahiro Watanabe, Riko Murakami,Shunta Hiroi,Kaisei Hosokawa,Taishi Yonetsu,Tsunekazu Kakuta
    2026
    引用
    AI阅读
    加入学术空间
    3Physician–Pharmacist PBPM for Intensive Lipid Management after Acute Myocardial Infarction
    Hiroya Aso,Riku Arai,So Iwabuchi,Toru Imai,Yuta Hotsubo, Tetsuro Nagao,Ran Sumida,Yudai Tanaka,Koichiro Hori,Katsunori Fukumoto,Yasunari Ebuchi,Suguru Migita,
    2026
    引用
    AI阅读
    加入学术空间
    4Physiological Within-Day Variation in Lipoprotein(a): is a Once-in-a-lifetime Measurement Sufficient for Cardiovascular Risk Evaluation?
    Shuxin Song,Satoshi Hirayama,Haruka Inaba, Atsushi Hori,Yuna Horiuchi, Yuri Ichikawa, Yutaka Kimura,Yoshifumi Fukushima,Tsuyoshi Ueno, Yuki Uehara,Takashi Miida

    Aims: Lipoprotein(a) (Lp(a)) is a strong risk factor for cardiovascular events, independent of low-density lipoprotein cholesterol (LDL-C). Because the Lp(a) concentration is largely determined by genetic factors, some dyslipidemia guidelines recommend a once-in-a-lifetime measurement of Lp(a). Furthermore, a non-fasting lipid profile assessment is allowed for initial screening of dyslipidemia. Although the LDL-C concentration decreases slightly throughout the day, the within-day variation of Lp(a) remains unknown. We aimed to investigate whether the Lp(a) concentration remains stable throughout the day. Methods: Lp(a) concentrations were measured at seven time points throughout the day in 34 patients using a latex turbidimetric immunoassay. The Lp(a) values are expressed in molar units, which are equivalent to those determined by a mass spectrometry-based reference measurement procedure. Results: We found that the Lp(a) concentrations decreased by 2.9 +/- 5.2 nmol/L at 14:00 (p<0.05), 3.6 +/- 4.8 nmol/L at 20:00 (p<0.001), and 2.9 +/- 5.1 nmol/L at 24:00 (p<0.05). The mean percent Lp(a) decreased significantly at 17:30 (-6.2 +/- 0.1%) and 24:00 (-7.0 +/- 0.1%) from the fasting level. Conclusion: The Lp(a) concentration decreases slightly, but significantly, throughout the day. Considering physiological variations, it is preferable to re-evaluate the Lp(a) concentration in those with a borderline elevation.

    2026
    引用
    AI阅读
    加入学术空间
    5Associations of Albuminuria and Egfr with Stiffness Parameter Β in Type 2 Diabetes
    Susumu Nakatani,Tomoaki Morioka,Yoshinori Kakutani, Shoko Miyamoto,Yuka Natsuki,Yuya Miki,Masafumi Kurajoh,Shinya Nakatani,Masanori Emoto

    Aims: The stiffness parameter 13 is a clinical index of arterial stiffness that reflects systemic atherosclerosis. Chronic kidney disease (CKD) is a major cardiovascular risk factor in type 2 diabetes; however, it remains unclear whether a reduced kidney function or albuminuria is more strongly associated with arterial stiffness. This study examined the relative associations of estimated glomerular filtration rate (eGFR) and urinary albumin-tocreatinine ratio (UACR) with stiffness parameter 13 in patients with type 2 diabetes. Methods: This cross-sectional study enrolled 1,924 patients with type 2 diabetes. The stiffness parameter 13 was assessed at the common carotid artery using ultrasonography. Results: The participants were 58.8% male, with a median age of 63 years and a median HbA1c level of 8.3%. According to univariate analyses, stiffness parameter 13 was significantly correlated with both eGFR and UACR. However, after adjusting for conventional cardiovascular risk factors, stiffness parameter 13 remained independently associated with UACR, whereas no independent association was observed with eGFR. Similar findings were observed when eGFR and albuminuria were analyzed according to the CKD categories. No significant interactions were observed between UACR and either age or body mass index in relation to stiffness parameter 13. Conclusions: In patients with type 2 diabetes, albuminuria, but not eGFR, was independently associated with stiffness parameter 13 after multivariable adjustment. These findings suggest that albuminuria may serve as a marker of local carotid arterial stiffening and vascular injury.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3188 篇论文

    高被引作者

    作者引用发文
    Shizuya Yamashita5790114
    Tomonori Okamura414490
    Kohji Shirai369460
    Yuji Matsuzawa352040
    Shun Ishibashi338552
    Hiroyuki Daida330071
    Tamio Teramoto307167
    Yokote Koutaro283450
    Hidenori Arai279845
    Jun Sasaki266146

    高产作者

    作者引用发文
    Shizuya Yamashita5790114
    Tomonori Okamura414490
    Mariko Harada-Shiba196781
    Hiroyuki Daida330071
    Tamio Teramoto307167
    Hayato Tada86163
    Hiroyasu Iso98063
    Hirotsugu Ueshima153061
    Kohji Shirai369460
    Katsuyuki Miura122355

    相关期刊

    Angiology
    Atherosclerosis
    American journal of hypertension
    Journal of clinical hypertension
    Cardiovascular diabetology
    Diabetes & vascular disease research
    Cardiovascular therapeutics
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
    Hypertension Research
    Current Vascular Pharmacology